Glaucoma

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.

Ever-widening knowledge base proves that there's more to it than controlling IOPs.

Baerveldt device showed better outcomes but required more interventions then Ahmed valve.

Dr Soloway discusses a novel approach for treating glaucoma known as the scleral spacing procedure (SSP) using PresView Scleral Implants

Performance compares favourably with trabeculectomy, in physician's experience

Strategy can improve patient compliance with glaucoma medication regimens.

Animals studies for neuroprotection in glaucoma have produced some promising results.

Dr Matthias Grieshaber advises surgeons to implement this technique into their armamentarium.

Results of an in vitro study of the potentially adverse efefcts of five different topical glaucoma medications and preservatives are revealed

Alternatives for reducing preservative loads must be considered when assessing the ocular surface of patients being treated in the long-term with IOP-lowering medications

A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.

There are still many challenges facing clinicians in the regeneration of the optic nerve. Dr M. Francesca Cordeiro reveals encouraging research results to help overcome these barriers.

Endoscopic cyclophotocoagulation combined with pars plana vitrectomy is a safe and highly effective technique for treating elevated IOP in pseudophakic eyes.

Dr Claes Feinbaum investigates emerging evidence that CCT is an important predictor for the development of primary open-angle glaucoma (POAG), and that it may be relevant as a predictor of both glaucoma progression and response to IOP-lowering medication

Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.

Relationship between IOP and scleral response shows promise, says ophthalmologist

New findings from the ongoing African Descent and Glaucoma Evaluation Study (ADAGES) support previous results indicating that ancestry differences in visual function in healthy eyes are likely to be a sign of early disease.

A glaucoma specialist outlines the seven deadly sins of glaucoma management that, if avoided, can greatly reduce the number of people who go blind from glaucoma. These points include making sure that diagnosis occurs promptly and that patient compliance is stressed.

What's the role for SLT?

Monitoring IOP pressure during sleeping hours, two doctors test it out for themselves

Glaucoma is a final pathway of amny different disorders that can lead to a common pattern of optic nerve and visual field damage

Investigating the tolerability and IOP reduction effect of switching from latanoprost to tafluprost in patients exhibiting ocular surface side effects

The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010

Clinicians pose several arguments for trabeculectomy and tube-shunt surgery